Skip to main content
. 2003 Jun 1;31(11):2944–2951. doi: 10.1093/nar/gkg392

Table 1. NOEs between distamycin and [TAGGGTTA]4 DNAa.

Distamycin group δ (p.p.m.) NOEs to [TAGGGTTA]4b
Pyrrole CH3-1 3.51 A2 H2, A2 H8,
    G5 H1, G5 H1′, A8 H2, T6 CH3
Pyrrole CH3-2 3.49 T1 H1′,
    G5 H1, G5 H8, T6 H6, T7 H1′, T7 H6
Pyrrole CH3-3 3.59 G3 H8,
    G5 H1′, G5 H8, A8 H2, T7 CH3
Pyrrole H3-1, H3-2 6.34 T1 CH3,
    T6 CH3, T6 H1′, T7 H1′
Pyrrole H3-3 6.51 T1 CH3,
    G5 H1′, T6 CH3, T6 H1′, T6 H2′, T7 H1′
Pyrrole H5-1 6.77 T1 CH3,
    T6 CH3, T6 H2′
Pyrrole H5-2 6.71 T6 CH3, T7 CH3
Pyrrole H5-3 6.80 T6 H1′, T7 CH3
Formyl HF 7.84 T1 CH3,
    T6 CH3

aNOESY τm = 250 ms, 35°C, D2O, molar ratio of 4:1 distamycin to G4 DNA molecule.

bFour additional weak NOEs exist between distamycin H3 and H5 protons and overlapping DNA deoxyribose protons.